Nymox Pharmaceutical
NYMX
#10797
Rank
NZ$31.88 M
Marketcap
Country
NZ$0.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.79 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$11.41 Million, an increase over its 2021 earnings that were of -NZ$21.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.79 Million-66.76%
2022 -NZ$11.41 Million-47.71%
2021 -NZ$21.81 Million6.61%
2020 -NZ$20.46 Million-10.91%
2019 -NZ$22.96 Million24.24%
2018 -NZ$18.48 Million-20.03%
2017 -NZ$23.11 Million2.71%
2016 -NZ$22.5 Million-63.86%
2015 -NZ$62.25 Million674.44%
2014 -NZ$8.04 Million-6.11%
2013 -NZ$8.57 Million-35.66%
2012 -NZ$13.31 Million-20.76%
2011 -NZ$16.8 Million38.33%
2010 -NZ$12.14 Million35.59%
2009 -NZ$8.96 Million11.8%
2008 -NZ$8.01 Million-12.94%
2007 -NZ$9.2 Million8.85%
2006 -NZ$8.46 Million36.5%
2005 -NZ$6.2 Million-4.4%
2004 -NZ$6.48 Million-14.58%
2003 -NZ$7.59 Million
2001 -NZ$5.57 Million-20.54%
2000 -NZ$7 Million21.72%
1999 -NZ$5.76 Million-25.56%
1998 -NZ$7.73 Million101.3%
1997 -NZ$3.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.38 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.50 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.21 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.37 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.40 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA